About the Study

Alagille Syndrome: A registry study of odevixibat in individuals with Alagille syndrome.

This study is enrolling participants who: - Have a diagnosis of Alagille syndrome - Currently taking odevixibat Alagille syndrome is a rare disease that can cause problems in the liver. The purpose of this study is to collect long-term data to see if odevixibat is safe and effective.

Interested in learning more?

Full Study Name: Ipsen Alagille Odevixibat Registry